# Exhibit Review — Gemini 3 Flash (Round 1)

**Role:** Visual exhibit advisor
**Model:** gemini-3-flash-preview (ai_studio)
**Paper:** paper.pdf
**Timestamp:** 2026-03-10T15:31:00.865120
**Route:** Direct Google API + PDF
**Tokens:** 22037 in / 1771 out
**Response SHA256:** 7fb0be70c53551cf

---

This review evaluates the visual exhibits of the paper "The Dog That Didn’t Bark: EU Medical Device Regulation and the Missing Innovation Decline." The paper follows top-tier journal conventions (e.g., AER/QJE) with a clean, professional aesthetic.

# Exhibit-by-Exhibit Review

## Main Text Exhibits

### Table 1: "Summary Statistics"
**Page:** 11
- **Formatting:** Professional. Use of Panels (A, B, C) is effective. Decimal alignment is generally good.
- **Clarity:** Clear. However, the mix of units (Index points vs. Counts) is dense.
- **Storytelling:** Essential. It establishes the base year (2021=100) and the variation in sample sizes across sectors.
- **Labeling:** Comprehensive notes.
- **Recommendation:** **REVISE**
  - Right-align the "N" and "Countries" columns to separate them from the statistical means/min/max.
  - In Panel B, the "Total Devices" column header is redundant; consider moving the risk class names to the left and the counts to a single column titled "Number of Registrations."

### Figure 1: "Industrial Production Trends: Medical Devices vs. Control Sectors"
**Page:** 15
- **Formatting:** Clean "ggplot2" style. Good use of a vertical dashed line for implementation.
- **Clarity:** The confidence intervals (shading) overlap significantly, creating a "muddy" look around 2017-2019.
- **Storytelling:** The primary visual proof of parallel trends.
- **Labeling:** Good.
- **Recommendation:** **REVISE**
  - Increase the line weight for the "Medical Devices (C325)" line to make it the clear focal point.
  - Lighten the alpha (transparency) of the control sector confidence intervals or consider removing shading for control sectors and keeping it only for the treatment group to reduce clutter.

### Figure 2: "EU Medical Device Production vs. US FDA 510(k) Clearances"
**Page:** 16
- **Formatting:** Dual-axis or dual-index? It is indexed to 2021=100.
- **Clarity:** Excellent. Very easy to parse in under 5 seconds.
- **Storytelling:** Strong external validity check. It shows the EU isn't unique in its upward trend.
- **Labeling:** Clear.
- **Recommendation:** **KEEP AS-IS**

### Table 2: "Effect of EU MDR on Medical Device Production"
**Page:** 17
- **Formatting:** Classic "stargazer/outreg2" style. Standard for top journals.
- **Clarity:** Logical progression from simple to complex specifications.
- **Storytelling:** The "Main Result" table. 
- **Labeling:** Significance stars and clustering are well-defined.
- **Recommendation:** **REVISE**
  - Column (4) has a "—" for the main interaction because it's a DDD. Explicitly label the bottom section "Fixed Effects" and "Controls" more clearly.
  - The note mentions Turkey, Switzerland, etc. It would be cleaner to have a row "Includes Non-EU Controls: Yes/No."

### Figure 3: "Event-Study Estimates: Effect of MDR on Medical Device Production"
**Page:** 18
- **Formatting:** High quality. Proper reference year (2020) omitted.
- **Clarity:** The 0-line is clear. The point estimates are distinct.
- **Storytelling:** This is the most important figure for a DiD paper. It validates the null.
- **Labeling:** "Differential Production Index" is a good y-axis label.
- **Recommendation:** **KEEP AS-IS**

### Figure 4: "EUDAMED Device Registrations by Risk Class"
**Page:** 19
- **Formatting:** Clean bar chart.
- **Clarity:** Very high.
- **Storytelling:** Supports the mechanism section (most devices are low-risk).
- **Labeling:** Labels on top of bars are helpful.
- **Recommendation:** **MOVE TO APPENDIX**
  - While interesting, the specific breakdown of EUDAMED is secondary to the causal production result. The text can summarize these percentages, and the figure can live in the appendix to keep the main text tight.

### Table 3: "Robustness Checks"
**Page:** 22
- **Formatting:** Clean panel structure.
- **Clarity:** Much better than most "all-in-one" robustness tables.
- **Storytelling:** Convincing.
- **Labeling:** Clear.
- **Recommendation:** **REVISE**
  - Panel C (Leave-one-country-out) is redundant with Figure 5 in the Appendix. Keep the table here but perhaps consolidate the "Alternative Control Sectors" into a single row or footnote if space is needed.

---

## Appendix Exhibits

### Table 4: "Medical Device Industry Characteristics: SBS Data"
**Page:** 31
- **Recommendation:** **KEEP AS-IS** (Standard descriptive appendix table).

### Figure 5: "Leave-One-Country-Out Estimates"
**Page:** 34
- **Recommendation:** **REVISE**
  - This is a "forest plot." The blue vertical line is the full estimate. It's very professional. However, the y-axis labels (Country Dropped) are slightly small. Increase font size.

### Figure 6: "Randomization Inference: Permutation Distribution"
**Page:** 35
- **Recommendation:** **KEEP AS-IS** (Standard check for few-cluster DiD).

### Figure 7: "Country-Level Production Trends"
**Page:** 36
- **Recommendation:** **PROMOTE TO MAIN TEXT**
  - This "spaghetti plot" shows the raw data underlying Figure 1. Top journals often like to see the raw country-level variation to ensure one country (like Lithuania) isn't driving the whole trend.

### Figure 8: "EUDAMED Manufacturer Countries"
**Page:** 37
- **Recommendation:** **REVISE**
  - The color scale (Higher-Risk Devices) is a bit hard to read against the green bars. Consider a simpler two-color bar (stacked bar chart) showing high-risk vs. low-risk count for each country.

### Table 5: "Standardized Effect Sizes for Main Outcomes"
**Page:** 40
- **Recommendation:** **REMOVE**
  - This table is "meta-analysis" style and feels out of place in a standard AER/QJE paper. The information (SDEs) can be mentioned in one sentence in the results section.

---

## Overall Assessment

- **Exhibit count:** 3 Main Tables, 4 Main Figures, 2 Appendix Tables, 4 Appendix Figures.
- **General quality:** Extremely high. The use of a consistent color palette (blues/oranges) and clear sans-serif fonts in figures matches the modern AER:Policy aesthetic.
- **Strongest exhibits:** Figure 3 (Event Study) and Figure 2 (EU vs. US).
- **Weakest exhibits:** Figure 1 (cluttered shading) and Table 5 (redundant).

**Missing exhibits:**
- A **Map Figure** showing the 6 treated EU countries vs. control countries would provide immediate geographic context for the reader.

**Top 3 Improvements:**
1. **Clean up Figure 1:** Reduce the overlap of the shaded confidence intervals. Use different line patterns (solid, dashed, dotted) for control sectors to improve black-and-white readability.
2. **Promote Figure 7:** Show the raw country-level data in the main text to address concerns about the small number of treated units (N=6).
3. **Streamline Table 3:** Remove Panel C from Table 3 since the visual forest plot (Figure 5) conveys the leave-one-out results more effectively. Move the forest plot to the main text if space allows.